Nancy Brown

Photo: Discovery trio

Vanderbilt’s Thomas Wang, M.D., left, Nancy Brown, M.D., and David Bader, Ph.D., explored the human determinants of cardiovascular disease and treatment at last week’s Flexner Discovery Lecture.

Vanderbilt researchers to discuss heart disease, treatment at lecture

Three Vanderbilt University researchers on the cutting edge of discovery will discuss the “human determinants of cardiovascular disease and treatment” during the next Flexner Discovery Lecture on Sept. 24.

Vanderbilt’s Brown, Crowe elected to IOM

Aronoff to lead Division of Infectious Diseases

David Aronoff, M.D., has been named the new director of Vanderbilt University Medical Center’s Division of Infectious Diseases.

Pollen counts boost risk of rare drug reaction: study

High pollen counts could trigger angioedema, a rare adverse reaction of Angiotension converting enzyme (ACE) inhibitors, Vanderbilt University researchers have found.

Clinical Pharmacology celebrates 50th anniversary

Since it was founded in 1963, the Vanderbilt Division of Clinical Pharmacology has pioneered “translational science” and continues to transform medical practice worldwide, speakers at the division’s 50th anniversary scientific symposium said last week.

1 2